INO — Inovio Pharmaceuticals Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual cashflow statement for Inovio Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-121	-167	-304	-280	-135
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	21.6	57	34	39.6	18.3
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-3.54	-71.1	50.4	19.8	-10.3
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities	-97.9	-178	-216	-216	-124
Capital Expenditures	-0.988	-1.52	-1.23	-0.969	-0.321
Purchase of Fixed Assets
Other Investing Cash Flow Items	-8.06	-57.3	-174	111	87.7
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-9.04	-58.8	-175	110	87.4
Financing Cash Flow Items	-0.355	2.38	0	0	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	105	465	211	81.8	5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-1.5	229	-180	-24.8	-32